The Jacinto Convit World Organization (JCWO) is a U.S. nonprofit and non-governmental organization incorporated in 2014, that contributes primarily to important areas of public health, such as cancer and infectious diseases in developing countries. JCWO focuses on cancer research and diagnostics through two main programs: Cancer Immunotherapy (CI) and Molecular Diagnostics (MD).
The CI program currently develops a personalized breast cancer therapeutic vaccine, named ConvitVax, designed by Dr. Jacinto Convit during his last years of life. Previous preclinical studies and a small human experience, showed this therapy to be potentially safe and effective, as well as possibly establishing immune system memory. ConvitVax is targeted to underprivileged patients who have very little or no access to new cancer treatments and in some cases to standard of care treatments.
The MD program supports the development and expansion of a personalized, precise and free of cost diagnostic service for various types of cancers and infectious diseases to benefit underprivileged and underserved patients in developing countries who do not have access to these specialized tests. Currently focused on Latin America.
- Execute clinical trials using Dr. Convit’s immunotherapy (ConvitVax), with the aim of making this immunotherapy available as a standard sole treatment or in combination with other therapies.
- Build collaborative networks with international organizations, hospitals, academia and multilaterals to perform and help sustain the execution of the clinical trials and further scientific research.
- Support the expansion of a cost-free molecular diagnostic service for cancer, in the Latin-American region.
- Create high social impact in third world countries by giving access to cancer-related health services and treatments to underprivileged patients, especially in places where public health conditions are highly deficient.
- Serve as a platform to preserve, promote and continue Dr. Convit’s legacy through scientific, educational, and social programs.